Time To Re Evaluate Becker Muscular Dystrophy

Time to Re-Evaluate Becker Muscular Dystrophy

Current Status
Not Enrolled
Price
Free
Get Started

Release Date: 7/2/2024

Expiration date: 7/2/2025

Activity Overview

This webinar featuring Sumit Verma, MD, of Emory University School of Medicine, will cover the core clinical features and patient-specific phenotypes of BMD, explore the impact of gene-modifying and replacement therapies for related neuromuscular diseases on the BMD treatment landscape, and will explore challenging diagnostic and management scenarios using case examples.

Target Audience

This activity is designed for an audience of nurses, nurse practitioners, pharmacists, physicians, physician associates.

Learning Objectives

Upon completion of the educational activity, participants should be able to:

Recognize symptoms of and use testing modalities to differentially diagnose BMD from other conditions that present similarly.

Review  clinical experience guidelines and recommended practices for managing BMD.

Utilize collaboration and communication between healthcare providers from different specialties (e.g., neurology, PT/OT, speech/swallow evaluation, etc.) to ensure coordinated care for patients with BMD.

Incorporate recent advances in clinical studies into patient care and provide guidance to patients on the benefit of and the opportunities for participation in BMD research.

Criteria for Success

To obtain a certificate of completion, a score of 70% or better on the post-test is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your certificate.  You must participate in the entire activity to receive credit. There is no fee to participate in this activity. If you have questions about this activity, please contact AKH Inc. at [email protected].


CE credit provided by AKH Inc., Advancing Knowledge in Healthcare. 

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and MDA. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.

Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

Credit being awarded: 1 ANCC contact hours

Pharmacists

AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 1 contact hour.

Physician Associate 

A blue circle with white text

Description automatically generated

AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid until 7/1/2025. PAs should only claim credit commensurate with the extent of their participation.

Nurse Practitioners

A black background with red and blue text

Description automatically generatedThis activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and MDA.  AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 1 contact hour(s) (which includes 0 hour(s) of pharmacology).

Social Workers

As a Jointly Accredited Organization, AKH Inc., Advancing Knowledge in Healthcare is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. AKH Inc. Advancing Knowledge in Healthcare maintains responsibility for this course. Social workers completing this course receive 1 continuing education credits.

Commercial Support

This activity is supported from an independent medical education grant from Edgewise Therapeutics.

DISCLOSURES
NameRelationshipCommercial Interest
Sumit Verma, MDN/ANothing to disclose
Bernadette Makar, MSN, APRN-BC, NP-C (planner/reviewer)N/ANothing to disclose
Dorothy Duffy, RPh (planner/reviewer)N/ANothing to disclose
Broc Pollinger, MSW, LSW, OSW-C, (planner/reviewer)N/ANothing to disclose
AKH Inc Staff and PlannersN/ANothing to disclose
MDA Staff and PlannersN/ANothing to disclose
All of the relevant financial relationships listed for these individuals have been mitigated.

Disclosures

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product 

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer 

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with “Opt Out” in the subject line.